APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesenchymal Stem Cells

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

Selected research

Market Structure

Global Mesenchymal Stem Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchMesenchymal Stem Cells Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesenchymal Stem Cells Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Mesenchymal Stem Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesenchymal Stem Cells Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesenchymal Stem Cells Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

The top 3 manufacturters of Mesenchymal Stem Cells include ​Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.

North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.

Read the full market overview

Report Includes

This report provides an overview of the global Mesenchymal Stem Cells market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mesenchymal Stem Cells and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mesenchymal Stem Cells revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Mesenchymal Stem Cells market size, projected growth trends, production technologies, key applications, and end-use industries.

Mesenchymal Stem Cells Segment by Company

Lonza

Thermo Fisher

Bio-Techne

ATCC

MilliporeSigma

PromoCell GmbH

Genlantis

Celprogen

Cell Applications

Cyagen Biosciences

Axol Bioscience

Mesenchymal Stem Cells Segment by Type

Human MSC

Mouse MSC

Rat MSC

Others

Mesenchymal Stem Cells Segment by Application

Research Institute

Hospital

Others

Mesenchymal Stem Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesenchymal Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesenchymal Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesenchymal Stem Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Mesenchymal Stem Cells in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mesenchymal Stem Cells industry.

Chapter 3: Detailed analysis of Mesenchymal Stem Cells companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mesenchymal Stem Cellsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mesenchymal Stem Cells Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Human MSC Table 3. Key Players of Mouse MSC Table 4. Key Players of Rat MSC Table 3. Key Players of Others Table 4. Global Mesenchymal Stem Cells Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Research Institute Table 6. Key Players of Hospital Table 7. Key Players of Others Table 8. Global Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Mesenchymal Stem Cells Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Mesenchymal Stem Cells Market Share by Region (2021-2026) Table 11. Global Mesenchymal Stem Cells Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Mesenchymal Stem Cells Market Share by Region (2027-2032) Table 13. Mesenchymal Stem Cells Industry Trends Table 14. Mesenchymal Stem Cells Industry Drivers Table 15. Mesenchymal Stem Cells Industry Opportunities and Challenges Table 16. Mesenchymal Stem Cells Industry Restraints Table 17. Global Mesenchymal Stem Cells Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Mesenchymal Stem Cells Revenue Market Share by Company (2021-2026) Table 19. Global Mesenchymal Stem Cells Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Mesenchymal Stem Cells Key Company Head Office and Area Served Table 21. Global Mesenchymal Stem Cells Company, Product Type & Application Table 22. Global Mesenchymal Stem Cells Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Mesenchymal Stem Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Mesenchymal Stem Cells Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Mesenchymal Stem Cells Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Mesenchymal Stem Cells Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Mesenchymal Stem Cells Revenue Market Share by Type (2021-2026) Table 29. Global Mesenchymal Stem Cells Revenue Market Share by Type (2027-2032) Table 30. Global Mesenchymal Stem Cells Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Mesenchymal Stem Cells Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Mesenchymal Stem Cells Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Mesenchymal Stem Cells Revenue Market Share by Application (2021-2026) Table 34. Global Mesenchymal Stem Cells Revenue Market Share by Application (2027-2032) Table 35. Lonza Company Information Table 36. Lonza Business Overview Table 37. Lonza Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Lonza Mesenchymal Stem Cells Product Portfolio Table 39. Lonza Recent Development Table 40. Thermo Fisher Company Information Table 41. Thermo Fisher Business Overview Table 42. Thermo Fisher Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Thermo Fisher Mesenchymal Stem Cells Product Portfolio Table 44. Thermo Fisher Recent Development Table 45. Bio-Techne Company Information Table 46. Bio-Techne Business Overview Table 47. Bio-Techne Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Bio-Techne Mesenchymal Stem Cells Product Portfolio Table 49. Bio-Techne Recent Development Table 50. ATCC Company Information Table 51. ATCC Business Overview Table 52. ATCC Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. ATCC Mesenchymal Stem Cells Product Portfolio Table 54. ATCC Recent Development Table 55. MilliporeSigma Company Information Table 56. MilliporeSigma Business Overview Table 57. MilliporeSigma Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. MilliporeSigma Mesenchymal Stem Cells Product Portfolio Table 59. MilliporeSigma Recent Development Table 60. PromoCell GmbH Company Information Table 61. PromoCell GmbH Business Overview Table 62. PromoCell GmbH Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. PromoCell GmbH Mesenchymal Stem Cells Product Portfolio Table 64. PromoCell GmbH Recent Development Table 65. Genlantis Company Information Table 66. Genlantis Business Overview Table 67. Genlantis Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Genlantis Mesenchymal Stem Cells Product Portfolio Table 69. Genlantis Recent Development Table 70. Celprogen Company Information Table 71. Celprogen Business Overview Table 72. Celprogen Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Celprogen Mesenchymal Stem Cells Product Portfolio Table 74. Celprogen Recent Development Table 75. Cell Applications Company Information Table 76. Cell Applications Business Overview Table 77. Cell Applications Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Cell Applications Mesenchymal Stem Cells Product Portfolio Table 79. Cell Applications Recent Development Table 80. Cyagen Biosciences Company Information Table 81. Cyagen Biosciences Business Overview Table 82. Cyagen Biosciences Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio Table 84. Cyagen Biosciences Recent Development Table 85. Axol Bioscience Company Information Table 86. Axol Bioscience Business Overview Table 87. Axol Bioscience Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Axol Bioscience Mesenchymal Stem Cells Product Portfolio Table 89. Axol Bioscience Recent Development Table 90. North America Mesenchymal Stem Cells Market Size by Type (2021-2026) & (US$ Million) Table 91. North America Mesenchymal Stem Cells Market Size by Type (2027-2032) & (US$ Million) Table 92. North America Mesenchymal Stem Cells Market Size by Application (2021-2026) & (US$ Million) Table 93. North America Mesenchymal Stem Cells Market Size by Application (2027-2032) & (US$ Million) Table 94. North America Mesenchymal Stem Cells Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Mesenchymal Stem Cells Market Size by Country (2021-2026) Table 96. North America Mesenchymal Stem Cells Market Size by Country (2027-2032) Table 97. Europe Mesenchymal Stem Cells Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe Mesenchymal Stem Cells Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe Mesenchymal Stem Cells Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe Mesenchymal Stem Cells Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe Mesenchymal Stem Cells Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Mesenchymal Stem Cells Market Size by Country (2021-2026) Table 103. Europe Mesenchymal Stem Cells Market Size by Country (2027-2032) Table 104. China Mesenchymal Stem Cells Market Size by Type (2021-2026) & (US$ Million) Table 105. China Mesenchymal Stem Cells Market Size by Type (2027-2032) & (US$ Million) Table 106. China Mesenchymal Stem Cells Market Size by Application (2021-2026) & (US$ Million) Table 107. China Mesenchymal Stem Cells Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Mesenchymal Stem Cells Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia Mesenchymal Stem Cells Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia Mesenchymal Stem Cells Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia Mesenchymal Stem Cells Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Mesenchymal Stem Cells Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Mesenchymal Stem Cells Market Size by Country (2021-2026) Table 114. Asia Mesenchymal Stem Cells Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Mesenchymal Stem Cells Product Image Figure 2. Global Mesenchymal Stem Cells Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Mesenchymal Stem Cells Market Share by Type: 2025 VS 2032 Figure 4. Human MSC Image Figure 5. Mouse MSC Image Figure 6. Rat MSC Image Figure 7. Others Image Figure 8. Global Mesenchymal Stem Cells Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Mesenchymal Stem Cells Market Share by Application: 2025 VS 2032 Figure 10. Research Institute Image Figure 11. Hospital Image Figure 12. Others Image Figure 13. Global Mesenchymal Stem Cells Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 15. Global Mesenchymal Stem Cells Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Mesenchymal Stem Cells Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Mesenchymal Stem Cells Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Mesenchymal Stem Cells Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Mesenchymal Stem Cells Revenue Market Share by Type (2021-2032) Figure 22. Global Mesenchymal Stem Cells Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Mesenchymal Stem Cells Revenue Market Share by Application (2021-2032) Figure 24. North America Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 25. North America Mesenchymal Stem Cells Market Share by Type (2021-2032) Figure 26. North America Mesenchymal Stem Cells Market Share by Application (2021-2032) Figure 27. North America Mesenchymal Stem Cells Market Share by Country (2021-2032) Figure 28. United States Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 29. Canada Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 31. Europe Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 32. Europe Mesenchymal Stem Cells Market Share by Type (2021-2032) Figure 33. Europe Mesenchymal Stem Cells Market Share by Application (2021-2032) Figure 34. Europe Mesenchymal Stem Cells Market Share by Country (2021-2032) Figure 35. Germany Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 36. France Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 38. Italy Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 39. Russia Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 41. China Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 42. China Mesenchymal Stem Cells Market Share by Type (2021-2032) Figure 43. China Mesenchymal Stem Cells Market Share by Application (2021-2032) Figure 44. Asia Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 45. Asia Mesenchymal Stem Cells Market Share by Type (2021-2032) Figure 46. Asia Mesenchymal Stem Cells Market Share by Application (2021-2032) Figure 47. Asia Mesenchymal Stem Cells Market Share by Country (2021-2032) Figure 48. Japan Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 52. India Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 53. Australia Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Mesenchymal Stem Cells Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Mesenchymal Stem Cells Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2021-2032) Figure 58. Brazil Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 63. UAE Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 65. Chile Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Human MSC
  • Mouse MSC
  • Rat MSC
  • Others
Applications
  • Research Institute
  • Hospital
  • Others
Companies covered
  • Lonza
  • Thermo Fisher
  • Bio-Techne
  • ATCC
  • MilliporeSigma
  • PromoCell GmbH
  • Genlantis
  • Celprogen
  • Cell Applications
  • Cyagen Biosciences
  • Axol Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Mesenchymal Stem Cells Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Human MSC
  5. 1.2.3 Mouse MSC
  6. 1.2.4 Rat MSC
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Mesenchymal Stem Cells Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Research Institute
  11. 1.3.3 Hospital
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Mesenchymal Stem Cells Growth Trends by Region
  15. 1.5.1 Global Mesenchymal Stem Cells Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Mesenchymal Stem Cells Market Size by Region (2021-2026)
  17. 1.5.3 Mesenchymal Stem Cells Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Mesenchymal Stem Cells Market Dynamics
  1. 2.1 Mesenchymal Stem Cells Industry Trends
  2. 2.2 Mesenchymal Stem Cells Industry Drivers
  3. 2.3 Mesenchymal Stem Cells Industry Opportunities and Challenges
  4. 2.4 Mesenchymal Stem Cells Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Mesenchymal Stem Cells Revenue by Company (2021-2026)
  2. 3.2 Global Mesenchymal Stem Cells Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Mesenchymal Stem Cells Key Company Head office and Area Served
  4. 3.4 Global Mesenchymal Stem Cells Company, Product Type & Application
  5. 3.5 Global Mesenchymal Stem Cells Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Mesenchymal Stem Cells Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Mesenchymal Stem Cells Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Mesenchymal Stem Cells Tier 1, Tier 2, and Tier 3
4 Mesenchymal Stem Cells Market by Type
  1. 4.1 Global Mesenchymal Stem Cells Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Mesenchymal Stem Cells Market Size by Type (2021-2032)
  3. 4.3 Global Mesenchymal Stem Cells Market Size Share by Type (2021-2032)
5 Mesenchymal Stem Cells Market by Application
  1. 5.1 Global Mesenchymal Stem Cells Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Mesenchymal Stem Cells Market Size by Application (2021-2032)
  3. 5.3 Global Mesenchymal Stem Cells Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Lonza
  2. 6.1.1 Lonza Company Information
  3. 6.1.2 Lonza Business Overview
  4. 6.1.3 Lonza Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Lonza Mesenchymal Stem Cells Product Portfolio
  6. 6.1.5 Lonza Recent Developments
  7. 6.2 Thermo Fisher
  8. 6.2.1 Thermo Fisher Company Information
  9. 6.2.2 Thermo Fisher Business Overview
  10. 6.2.3 Thermo Fisher Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Thermo Fisher Mesenchymal Stem Cells Product Portfolio
  12. 6.2.5 Thermo Fisher Recent Developments
  13. 6.3 Bio-Techne
  14. 6.3.1 Bio-Techne Company Information
  15. 6.3.2 Bio-Techne Business Overview
  16. 6.3.3 Bio-Techne Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bio-Techne Mesenchymal Stem Cells Product Portfolio
  18. 6.3.5 Bio-Techne Recent Developments
  19. 6.4 ATCC
  20. 6.4.1 ATCC Company Information
  21. 6.4.2 ATCC Business Overview
  22. 6.4.3 ATCC Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 ATCC Mesenchymal Stem Cells Product Portfolio
  24. 6.4.5 ATCC Recent Developments
  25. 6.5 MilliporeSigma
  26. 6.5.1 MilliporeSigma Company Information
  27. 6.5.2 MilliporeSigma Business Overview
  28. 6.5.3 MilliporeSigma Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 MilliporeSigma Mesenchymal Stem Cells Product Portfolio
  30. 6.5.5 MilliporeSigma Recent Developments
  31. 6.6 PromoCell GmbH
  32. 6.6.1 PromoCell GmbH Company Information
  33. 6.6.2 PromoCell GmbH Business Overview
  34. 6.6.3 PromoCell GmbH Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 PromoCell GmbH Mesenchymal Stem Cells Product Portfolio
  36. 6.6.5 PromoCell GmbH Recent Developments
  37. 6.7 Genlantis
  38. 6.7.1 Genlantis Company Information
  39. 6.7.2 Genlantis Business Overview
  40. 6.7.3 Genlantis Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Genlantis Mesenchymal Stem Cells Product Portfolio
  42. 6.7.5 Genlantis Recent Developments
  43. 6.8 Celprogen
  44. 6.8.1 Celprogen Company Information
  45. 6.8.2 Celprogen Business Overview
  46. 6.8.3 Celprogen Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Celprogen Mesenchymal Stem Cells Product Portfolio
  48. 6.8.5 Celprogen Recent Developments
  49. 6.9 Cell Applications
  50. 6.9.1 Cell Applications Company Information
  51. 6.9.2 Cell Applications Business Overview
  52. 6.9.3 Cell Applications Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Cell Applications Mesenchymal Stem Cells Product Portfolio
  54. 6.9.5 Cell Applications Recent Developments
  55. 6.10 Cyagen Biosciences
  56. 6.10.1 Cyagen Biosciences Company Information
  57. 6.10.2 Cyagen Biosciences Business Overview
  58. 6.10.3 Cyagen Biosciences Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio
  60. 6.10.5 Cyagen Biosciences Recent Developments
  61. 6.11 Axol Bioscience
  62. 6.11.1 Axol Bioscience Company Information
  63. 6.11.2 Axol Bioscience Business Overview
  64. 6.11.3 Axol Bioscience Mesenchymal Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Axol Bioscience Mesenchymal Stem Cells Product Portfolio
  66. 6.11.5 Axol Bioscience Recent Developments
7 North America
  1. 7.1 North America Mesenchymal Stem Cells Market Size (2021-2032)
  2. 7.2 North America Mesenchymal Stem Cells Market Size by Type
  3. 7.2.1 North America Mesenchymal Stem Cells Market Size by Type (2021-2026)
  4. 7.2.2 North America Mesenchymal Stem Cells Market Size by Type (2027-2032)
  5. 7.2.3 North America Mesenchymal Stem Cells Market Share by Type (2021-2032)
  6. 7.3 North America Mesenchymal Stem Cells Market Size by Application
  7. 7.3.1 North America Mesenchymal Stem Cells Market Size by Application (2021-2026)
  8. 7.3.2 North America Mesenchymal Stem Cells Market Size by Application (2027-2032)
  9. 7.3.3 North America Mesenchymal Stem Cells Market Share by Application (2021-2032)
  10. 7.4 North America Mesenchymal Stem Cells Market Size by Country
  11. 7.4.1 North America Mesenchymal Stem Cells Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Mesenchymal Stem Cells Market Size by Country (2021-2026)
  13. 7.4.3 North America Mesenchymal Stem Cells Market Size by Country (2027-2032)
  14. 7.4.4 North America Mesenchymal Stem Cells Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Mesenchymal Stem Cells Market Size (2021-2032)
  2. 8.2 Europe Mesenchymal Stem Cells Market Size by Type
  3. 8.2.1 Europe Mesenchymal Stem Cells Market Size by Type (2021-2026)
  4. 8.2.2 Europe Mesenchymal Stem Cells Market Size by Type (2027-2032)
  5. 8.2.3 Europe Mesenchymal Stem Cells Market Share by Type (2021-2032)
  6. 8.3 Europe Mesenchymal Stem Cells Market Size by Application
  7. 8.3.1 Europe Mesenchymal Stem Cells Market Size by Application (2021-2026)
  8. 8.3.2 Europe Mesenchymal Stem Cells Market Size by Application (2027-2032)
  9. 8.3.3 Europe Mesenchymal Stem Cells Market Share by Application (2021-2032)
  10. 8.4 Europe Mesenchymal Stem Cells Market Size by Country
  11. 8.4.1 Europe Mesenchymal Stem Cells Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Mesenchymal Stem Cells Market Size by Country (2021-2026)
  13. 8.4.3 Europe Mesenchymal Stem Cells Market Size by Country (2027-2032)
  14. 8.4.4 Europe Mesenchymal Stem Cells Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Mesenchymal Stem Cells Market Size (2021-2032)
  2. 9.2 China Mesenchymal Stem Cells Market Size by Type
  3. 9.2.1 China Mesenchymal Stem Cells Market Size by Type (2021-2026)
  4. 9.2.2 China Mesenchymal Stem Cells Market Size by Type (2027-2032)
  5. 9.2.3 China Mesenchymal Stem Cells Market Share by Type (2021-2032)
  6. 9.3 China Mesenchymal Stem Cells Market Size by Application
  7. 9.3.1 China Mesenchymal Stem Cells Market Size by Application (2021-2026)
  8. 9.3.2 China Mesenchymal Stem Cells Market Size by Application (2027-2032)
  9. 9.3.3 China Mesenchymal Stem Cells Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Mesenchymal Stem Cells Market Size (2021-2032)
  2. 10.2 Asia Mesenchymal Stem Cells Market Size by Type
  3. 10.2.1 Asia Mesenchymal Stem Cells Market Size by Type (2021-2026)
  4. 10.2.2 Asia Mesenchymal Stem Cells Market Size by Type (2027-2032)
  5. 10.2.3 Asia Mesenchymal Stem Cells Market Share by Type (2021-2032)
  6. 10.3 Asia Mesenchymal Stem Cells Market Size by Application
  7. 10.3.1 Asia Mesenchymal Stem Cells Market Size by Application (2021-2026)
  8. 10.3.2 Asia Mesenchymal Stem Cells Market Size by Application (2027-2032)
  9. 10.3.3 Asia Mesenchymal Stem Cells Market Share by Application (2021-2032)
  10. 10.4 Asia Mesenchymal Stem Cells Market Size by Country
  11. 10.4.1 Asia Mesenchymal Stem Cells Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Mesenchymal Stem Cells Market Size by Country (2021-2026)
  13. 10.4.3 Asia Mesenchymal Stem Cells Market Size by Country (2027-2032)
  14. 10.4.4 Asia Mesenchymal Stem Cells Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Mesenchymal Stem Cells Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Mesenchymal Stem Cells Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Mesenchymal Stem Cells Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst